Parvimonas micra: Difference between revisions
From IDWiki
Parvimonas micra
(Created page with "{{DISPLAYTITLE:''Parvimonas micra''}} == Background == * Stain::Gram-positive Cellular respiration::anaerobic Shape::coccus * Commensal member of the gut microbiota, occasionally urogenital tract and skin == Clinical Manifestations == * Chronic apical periodontitis * Bacteremia<ref>Watanabe, T., Hara, Y., Yoshimi, Y. ''et al.'' Clinical characteristics of bloodstream infection by ''Parvimonas micra'': retrospective case series and literature review. '...") |
mNo edit summary |
||
| Line 9: | Line 9: | ||
* Chronic apical periodontitis |
* Chronic apical periodontitis |
||
| + | * Bacteremia[[CiteRef::watanabe2020cl]] |
||
| − | * Bacteremia<ref>Watanabe, T., Hara, Y., Yoshimi, Y. ''et al.'' Clinical characteristics of bloodstream infection by ''Parvimonas micra'': retrospective case series and literature review. ''BMC Infect Dis'' 20, 578 (2020). https://doi.org/10.1186/s12879-020-05305-y</ref> |
||
** Can be from discitis (30%), oropharyngeal infection (25%), intraabdominal abscess (15%), GI tract infection (10%), endocarditis (10%), and septic pulmonary emboli (10%) |
** Can be from discitis (30%), oropharyngeal infection (25%), intraabdominal abscess (15%), GI tract infection (10%), endocarditis (10%), and septic pulmonary emboli (10%) |
||
** Up to half have polymicrobial bacteremia |
** Up to half have polymicrobial bacteremia |
||
Latest revision as of 13:14, 27 September 2024
Background
- Gram-positive anaerobic coccus
- Commensal member of the gut microbiota, occasionally urogenital tract and skin
Clinical Manifestations
- Chronic apical periodontitis
- Bacteremia1
- Can be from discitis (30%), oropharyngeal infection (25%), intraabdominal abscess (15%), GI tract infection (10%), endocarditis (10%), and septic pulmonary emboli (10%)
- Up to half have polymicrobial bacteremia
- May also be involved in meningitis, brain abscess, and neck abscess
Management
- Fairly susceptible, including to penicillin, piperacillin-tazobactam, meropenem, clindamycin
References
- ^ Tsuyoshi Watanabe, Yuki Hara, Yusuke Yoshimi, Yoshiro Fujita, Masamichi Yokoe, Yoshinori Noguchi. Clinical characteristics of bloodstream infection by Parvimonas micra: retrospective case series and literature review. BMC Infectious Diseases. 2020;20(1). doi:10.1186/s12879-020-05305-y.
